Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

830.95 +96.05 (+13.07%)
Streaming Delayed Price Updated: 9:37 AM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,744,512
Open 840.80
Bid (Size) 830.25 (3)
Ask (Size) 832.38 (2)
Prev. Close 734.90
Today's Range 821.84 - 843.18
52wk Range 677.09 - 972.53
Shares Outstanding N/A
Dividend Yield 0.63%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
ECB Cuts Interest Rates For 7th Time In A Row As Trump Tariffs Spark Growth Fears – Warns Of ‘Tightening’ Impact From Trade Tensions
The central bank acknowledged that the euro area economy has been building up some resilience against global shocks, but the growth outlook has deteriorated due to rising trade tensions. 
Via Stocktwits
Topics ETFs Economy Government
Exposures Economy Interest Rates Political
Eli Lilly’s Weight Loss Pill Succeeds In Phase 3 Trials On Type-2 Diabetes Patients
The company says orforglipron is the first oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist to successfully complete a Phase 3 trial. 
Via Stocktwits
Topics Economy Government Stocks
Exposures Interest Rates Political US Equities

Performance

YTD
+6.8%
+6.8%
1 Month
+0.8%
+0.8%
3 Month
+11.3%
+11.3%
6 Month
-9.3%
-9.3%
1 Year
+11.3%
+11.3%

More News

Read More
Eli Lilly Stock Rockets On Weight-Loss Pill Progress
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety
Eli Lilly's Oral GLP-1 Drug Orforglipron Hits Phase 3 Goals In Diabetes Trial, Stock Soars
Via Benzinga
Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction
Via Benzinga
Topics Government
Exposures Political
Europe Approves Eisai-Biogen's Alzheimer's Drug 'Under Strict Conditions' After Initial Negative Opinion
Via Benzinga
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
Via NewMediaWire
Exposures Product Safety
BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease
Via TheNewswire.com
Exposures Product Safety
Skye Bioscience's Obesity Candidate Shows 30% Weight Loss When Combined With Eli Lilly's Blockbuster Drug In Animal Models
Via Benzinga
Eli Lilly's Mounjaro Launch Triggers Weight-Loss Drug Craze In India, Novo Nordisk Seeks To Move Up Wegovy Launch
Via Benzinga
Down 71%, Should You Buy the Dip on Viking Therapeutics Stock?
Via The Motley Fool
Verve Therapeutics Touts Positive Data From Gene Editing Medicine To Lower Cholesterol After Single Dose
Via Benzinga
Why Eli Lilly, Novo Nordisk, and Viking Therapeutics Stocks All Popped Today
Via The Motley Fool
What's Going On With Viking Therapeutics, Structure Therapeutics Stock On Monday?
Via Benzinga
Eli Lilly Stock: A Deep Dive Into Analyst Perspectives (7 Ratings)
Via Benzinga
Pfizer Ends Development Of Weight Loss Pill Due To Potential Drug-Induced Liver Injury In A Patient
Via Stocktwits
Topics Government
Exposures Political
Pfizer Scraps Obesity Pill After Potential Drug-Tied Liver Injury
Via Investor's Business Daily
Investing $60,000 in These 3 Funds Could Generate Annual Income of Over $6,500
Via The Motley Fool
Novartis Commits $23 Billion To Expand US Manufacturing Over Five Years, Despite Tariffs Uncertainties
Via Benzinga
3 Value Stocks in the Doghouse
Via StockStory
Building Wealth Through Economics: A Patriotic Investor’s Guide To Tariffs 2.0 And Why
Via Talk Markets
Topics ETFs Stocks / Equities World Trade
Exposures Tariff
Eli Lilly, AbbVie, Bristol Myers, Regeneron, And Other Pharma Companies Slide As Donald Trump Confirms Tariffs On Pharma Companies
Via Benzinga
Topics Government World Trade
Exposures Political Tariff
China Deal Is 'Going To Work Out,' Trump Says As Stocks Bounce From Session Lows
Via Benzinga
Topics Government
Exposures Political
Select Medical, Phreesia, Eli Lilly, Pfizer, and Brink's Shares Are Falling, What You Need To Know
Via StockStory
Topics Economy Government World Trade
Exposures Economy Political Tariff
Trump Wants RFK Jr. To 'Go Wild' On Health Care. What This Means For Biotech Stocks.
Via Investor's Business Daily
Topics Government
Exposures Political Product Safety

Frequently Asked Questions

Is Eli Lilly publicly traded?
Yes, Eli Lilly is publicly traded.
What exchange does Eli Lilly trade on?
Eli Lilly trades on the New York Stock Exchange
What is the ticker symbol for Eli Lilly?
The ticker symbol for Eli Lilly is LLY on the New York Stock Exchange
What is the current price of Eli Lilly?
The current price of Eli Lilly is 830.95
When was Eli Lilly last traded?
The last trade of Eli Lilly was at 04/17/25 09:37 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.